Webinars

ERN GENTURIS e-Training Programme

Webinars

As part of the ERN GENTURIS e-training programme, each of our webinars provides either a general overview of a genturis-related topic or an in-depth look at one of the genturis diseases from a specific healthcare perspective. An important goal of our webinar series is to cover each genturis from several perspectives in order to create a comprehensive overview of the currently available knowledge for every genturis.

All our webinars include at least one speaker that is a member of ERN GENTURIS. The target audience for the webinars consists of clinicians, genetic counsellors, clinical scientists and other genetics health professionals. The webinars last approximately 30-40 minutes, and viewers have the opportunity to send questions on the subject area, which will be addressed in a question & answer session afterwards. Webinars are usually held on Wednesday afternoons.

 

Register for upcoming webinars:

Date	Time	Speaker	Title	Registration*
8-10-2025	16:00-17:00 CEST	Pernille Axél Gregersen	Heritable retinoblastoma – long-term follow-up and care	register
12-11-2025	16:00-17:00 CET	Marjolijn Jongmans	Hereditary childhood cancer	pending
10-12-2025	16:00-17:00 CET	Giovanni Tallini	DICER1-associated thyroid tumours - the pathologist’s perspective	pending

* Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private computer and internet connection.

View previous webinars:

The previous webinars listed below are subdivided into the following categories:

• General

• Thematic group 1: Schwannomatosis and neurofibromatosis

  • Neurofibromatosis 1

• Thematic group 2: Lynch and polyposis

  • Lynch syndrome

  • Polyposis syndromes

• Thematic group 3: Hereditary breast and ovarian cancer syndrome (HBOC)

• Thematic group 4: Other rare – predominantly malignant – genturis

  • PTEN hamartoma tumour syndrome (PHTS, Cowden syndrome)

  • Heritable TP53-related cancer syndrome (hTP53rc syndrome)/Li-Fraumeni syndrome (LFS)

  • Birt-Hogg-Dubé syndrome (BHD syndrome)

  • Familial melanoma

  • Constitutional Mismatch Repair Deficiency (CMMRD)

  • Diffuse Gastric and Lobular Breast Cancer Syndrome (DGLBC)

  • Naevoid basal cell carcinoma syndrome / Gorlin syndrome (NBCCS/GS)

  • Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)

  • von-Hippel Lindau disease (vHL)

  • Hereditary pheochromocytoma-paraganglioma

  • MBD4-related tumour predisposition syndrome

 

 

General

Date	Speaker	Title	View**
23-06-2025	Janneke Schuurs-Hoeijmakers	Mosaicism in oncogenetics	view
12-03-2025	Richarda de Voer	Genetic cancer predisposition in adolescents and young adults	view
11-12-2024	Kenny Rodriguez-Wallberg	Fertility preserving measures in hereditary cancer syndromes – the oncofertility perspective	view
24-04-2024	Maria Haanpää	Variant interpretation and classification in cancer genes – Zipper model	view
13-03-2024	Verena Steinke-Lange	Hereditary tumour syndromes for gastroenterologists	view
11-10-2023	Bev Speight	Haematological malignancies – a genetic counselling perspective	view
24-05-2023	Rolf Sijmons	Liquid biopsy: the future of surveillance in individuals with inherited cancer predisposition?	view
26-04-2023	Marc Tischkowitz and Judith Balmaña	Mainstreaming – method or madness?	view
08-03-2023	Richarda de Voer	Genetics of (new) colorectal cancer & polyposis syndromes	view
25-01-2023	Stefan Aretz	Genetics 30 years after the discovery of APC	view
14-12-2022	Evelin Schröck	Precision Oncology – conclusions for human genetics and genetic tumor risk syndromes	view
23-11-2022	Ann Nordgren	Childhood cancer and genetic tumour risk syndromes – the geneticist's perspective	view
05-10-2022	Maurizio Genuardi	The process of variant classification and its implications for clinical management	view
08-06-2022	Rolf Sijmons	Practical use of gene panels in the diagnostics of suspected hereditary cancer predisposition	view
20-04-2022	Ariane Weinman, Claas Röhl, Tamara Hussong Milagre	How EURORDIS and other patient organisations collaborate with the ERN GENTURIS	view
06-04-2022	Stefan Aretz	How to identify families with tumour risk syndromes	view
24-11-2021	Stefan Aretz	Somatic Mosaicism in Tumour Genetics	view
29-09-2021	Katharina Wimmer	Replication Error Repair defects in cancer and cancer predisposition	view
15-09-2021	Nicoline Hoogerbrugge	ERN GENTURIS: The EU highway for these rare diseases	view
16-06-2021	Svetlana Lagercrantz	Risk reducing measures in Cancer Risk syndromes	view
24-02-2021	Ignacio Blanco Guillermo	Cancer genetic counseling and previvorship in an era of rapid change	view
27-01-2021	Kathleen Claes	Variants identified in tumors can be germline – when to refer for germline testing	view
17-06-2020	Marjolijn Ligtenberg	The Genetic Basis of Cancer	view
15-04-2020	Maurizio Genuardi	The heritability of cancer	view

** A recording of each webinar will be made available within a week after broadcast. Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and internet connection.

 

Thematic group 1: Schwannomatosis and neurofibromatosis

Date	Speaker	Title	View**
07-06-2023	Gareth Evans	New ERN GENTURIS NF1 guidelines and update on NF2 and SCHWN nomenclature	view
27-01-2022	Sirkku Peltonen & Pierre Wolkenstein	Cutaneous neurofibromas	view
28-10-2020	Gareth Evans	Neurocutaneous tumour syndromes	view

** A recording of each webinar will be made available within a week after broadcast. Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and internet connection.

 

Neurofibromatosis type 1

Date	Speaker	Title	View**
07-06-2023	Gareth Evans	New ERN GENTURIS NF1 guidelines and update on NF2 and SCHWN nomenclature	view
07-12-2021	Eric Legius	Legius syndrome and its link with Neurofibromatosis type 1	view
10-11-2021	Rianne Oostenbrink	NF1 from the pediatric perspective	view

 

Thematic group 2: Lynch and polyposis

Date	Speaker	Title	View**
13-03-2024	Verena Steinke-Lange	Hereditary tumour syndromes for gastroenterologists	view
08-03-2023	Richarda de Voer	Genetics of (new) colorectal cancer & polyposis syndromes	view
25-01-2023	Stefan Aretz	Genetics 30 years after the discovery of APC	view

** A recording of each webinar will be made available within a week after broadcast. Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and internet connection.

 

Lynch syndrome

Date	Speaker	Title	View**
20-11-2024	Marjolijn Ligtenberg	Molecular profiles of noncanonical malignancies from patients with Lynch syndrome or a BRCA1/2 pathogenic variant may generate putative options for personalized treatment.	view
09-11-2023	Monique van Leerdam	Lynch syndrome – the gastroenterologist’s perspective	view
06-09-2023	Elke Holinski-Feder	Lynch syndrome update	view
13-10-2021	Iosune Baraibar	Update in therapeutic options for Lynch-associated colorectal cancer patients	view
30-09-2020	Elke Holinski-Feder	HNPCC related tumour risk syndromes  – pathomechanisms and clinical implications	view

 

Polyposis syndromes

Date	Speaker	Title	View**
09-04-2024	Lenka Foretova	Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS) – not so infrequent disease	view
25-10-2023	Anja Wagner & Esther Korpershoek	Peutz-Jeghers syndrome – the clinical genetic perspective	view
22-03-2023	Marco Vitellaro	Familial adenomatous polyposis - the surgeon's perspective	view
06-02-2023	Chella van der Post	Hereditary gastrointestinal cancer – the pathologist's perspective	view
13-01-2021	Stefan Aretz	Gastrointestinal polyposis syndromes	view

 

Thematic group 3: Hereditary breast and ovarian cancer syndrome (HBOC)

Date	Speaker	Title	View**
24-04-2025	Sophie Frank	Use of hormones in BRCA carriers: hormonal replacement therapy, oral contraception, ovarian stimulation – is it safe?	view
20-11-2024	Marjolijn Ligtenberg	Molecular profiles of noncanonical malignancies from patients with Lynch syndrome or a BRCA1/2 pathogenic variant may generate putative options for personalized treatment.	view
23-10-2024	Tjoung-Won Simon-Park	Adjuvant therapy options for hereditary breast cancer	view
22-05-2024	Fátima Vaz & Teresa Duarte	Molecular Diagnosis of the BRCA2 c.156_157insAlu, a Portuguese founder Pathogenic Variant.	view
09-11-2022	Angelique Flöter Rådestad	Hereditary breast- and ovarian cancer, aspects on risk reducing measures and hormonal replacement – the gyne-oncologist's perspective	view
26-10-2022	Janez Žgajnar	Prophylactic mastectomies – the surgeon's perspective	view
22-06-2022	Joanne de Hullu	Prevention of ovarian cancer	view
23-02-2022	Marc Tischkowitz	Polygenic Risk Scores in breast and ovarian cancer risk prediction – ready for the clinic?	view
10-02-2021	Judith Balmaña	Germline mutations as a therapeutic target in breast cancer	view
20-05-2020	Marc Tischkowitz	Hereditary Breast and Ovarian Cancer - BRCA1, BRCA2 and the basics	view

** A recording of each webinar will be made available within a week after broadcast. Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and internet connection.

 

Thematic group 4: Other rare – predominantly malignant – genturis

 

PTEN hamartoma tumour syndrome (PHTS, Cowden syndrome)

Date	Speaker	Title	View**
14-02-2024	Nicoline Hoogerbrugge	PTEN hamartoma tumour syndrome (PHTS, Cowden syndrome): update on cancer risks and yield of surveillance	view
06-02-2023	Chella van der Post	Hereditary gastrointestinal cancer – the pathologist's perspective	view
21-10-2021	Jolanda Schieving	PTEN hamartoma tumour syndrome in childhood	view
09-12-2020	Nicoline Hoogerbrugge	Recognising PTEN hamartoma tumour syndrome for early cancer detection	view

 

 

Heritable TP53-related cancer syndrome (hTP53rc syndrome)/Li-Fraumeni syndrome (LFS)

Date	Speaker	Title	View**
27-03-2024	Thomas van Overeem Hansen	TP53 variant classification	view
31-03-2021	Yvonne Brandberg	Psychological aspects on the TP53 related cancer syndromes	view
14-10-2020	Thierry Frebourg	Li-Fraumeni and heritable TP53-related cancer syndromes	view

 

Birt-Hogg-Dubé syndrome (BHD syndrome)

Date	Speaker	Title	View**
25-09-2024	Marianne Geilswijk	ERN GENTURIS guideline on Birt-Hogg-Dubé syndrome diagnosis, surveillance and management	view

 

 

Familial melanoma

Date	Speaker	Title	View**
24-06-2024	Barbara Perić	Familal melanoma - the surgeon’s perspective	view
28-02-2024	Remco van Doorn	Familial melanoma - the dermatologist's perspective	view
09-03-2022	Karin Wadt	Genetic predisposition to melanoma	view

 

 

Constitutional Mismatch Repair Deficiency (CMMRD)

Date	Speaker	Title	View**
22-01-2025	Katharina Wimmer & Chrystelle Colas	ERN GENTURIS guideline on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management	view
26-05-2021	Chrystelle Colas	Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome	view

 

 

Diffuse Gastric and Lobular Breast Cancer Syndrome (DGLBC)

Date	Speaker	Title	View**
22-11-2023	Carla Oliveira	CTNNA1 germline variants: genotype-phenotype associations	view
06-02-2023	Chella van der Post	Hereditary gastrointestinal cancer – the pathologist's perspective	view
24-05-2022	Fátima Carneiro	Pathology of CDH1-related diffuse gastric cancer	view
11-05-2021	Tanya Bisseling	A personal history about hereditary diffuse gastric cancer	view
25-11-2020	Carla Oliveira	Hereditary Gastric Cancer	view

 

 

Naevoid basal cell carcinoma syndrome / Gorlin syndrome (NBCCS/GS)

Date	Speaker	Title	View**
28-10-2020	Gareth Evans	Neurocutaneous tumour syndromes (including Gorlin)	view

 

Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)

Date	Speaker	Title	View**
06-12-2023	Eamonn Maher	Hereditary Leiomyomatosis and Renal Cell Cancer	view

 

von-Hippel Lindau disease (vHL)

Date	Speaker	Title	View**
22-06-2023	Marieke de Laat	von Hippel-Lindau disease - the endocrinologist’s perspective	view
17-03-2021	Eamonn Maher	Von Hippel-Lindau disease: from clinic to gene and back	view

 

Hereditary pheochromocytoma-paraganglioma

Date	Speaker	Title	View**
11-11-2020	Evelin Schröck	Pheochromocytoma/ paraganglioma – benefit of combined germline and tumour testing for PPGL patients	view

 

MBD4-related tumour predisposition syndrome

Date	Speaker	Title	View**
08-03-2023	Richarda de Voer	Genetics of (new) colorectal cancer & polyposis syndromes	view

** A recording of each webinar will be made available within a week after broadcast. Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and internet connection.

 

Live webinar attendees by ERN GENTURIS member country

Updated on 4-4-2025